Rosen Law says Insulet investors may seek lead plaintiff role in securities suit

Rosen Law Firm said investors who bought Insulet Corporation securities between Feb. 21, 2025, and May 26, 2026, may seek to lead an already filed securities class action, with an Aug. 31, 2026, deadline to apply.

The notice, published by PR Newswire and dated Aug. 17, 2026 in the body text, identifies Insulet as Nasdaq-listed under PODD. It says purchasers during the class period may be entitled to compensation and that no out-of-pocket fees or costs are required under a contingency fee arrangement.

Rosen Law said the action concerns alleged false and misleading statements and failures to disclose that Insulet’s manufacturing controls and procedures were defective. The notice says those defects allegedly created a foreseeable heightened risk of safety-regulation violations and injury risk.

According to the notice, the lawsuit alleges that public statements were materially false and misleading during the class period and that investors suffered damages when the true details entered the market. The notice does not say how large the alleged losses were.

The brief also includes standard class-action language. It says no class has been certified, investors are not represented unless they retain counsel, and they may choose their own lawyer or do nothing at this stage. It also says an investor’s ability to share in any potential recovery does not depend on serving as lead plaintiff.

Rosen Law said investors can join the case through its website, by phone or by email. The notice also repeats the firm’s background in securities class actions and shareholder derivative litigation, along with prior settlements and rankings. Those claims were included in the firm’s promotional material inside the notice.

Investors who want to seek lead plaintiff status face the Aug. 31 deadline listed in the notice. The class action will then proceed through the usual court process unless it is later resolved or modified.

Sources

• PR Newswire notice: “Insulet Deadline: PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit”

Editorial note: This article was prepared with AI assistance and includes source attribution for reader review.